Submit manuscript...
International Journal of
eISSN: 2573-2889

Molecular Biology: Open Access

Research Article Volume 3 Issue 2

Candidate variants in MLC1gene causing Megalencephalic Leukodystrophy using in silico prediction methods

Mutaz Amin

Department of Biochemistry, University of Khartoum, Sudan

Correspondence: Mutaz Amin, Department of Biochemistry, Faculty of Medicine, University of Khartoum, Sudan

Received: August 07, 2017 | Published: March 1, 2018

Citation: Amin M. Candidate variants in MLC1 gene causing Megalencephalic Leukodystrophy using in silico prediction methods. Int J Mol Biol Open Access. 2018;3(2):49-52. DOI: 10.15406/ijmboa.2018.03.00049

Download PDF

Abstract

Megalencephalic Leukodystrophy with sub cortical cysts is a type of Demyelinating Leukodystrophy caused by mutations in MLC1 gene. Various mutations in MLC1 gene have been reported worldwide but high throughput technologies aimed to discover novel variants underlying this disorder are scarce and there is a lot yet to be discovered. In silico analysis of SNPs in a gene known to cause a disease is a well effective and economic method of analyzing known variants deposited in public databases. This article aimed to analyze all SNPs in MLC1 gene in order to be used in screening programs for patients with Megalencephalic Leukodystrophy. The SNPs in MLC1 gene were retrieved from NCBI db SNP. Variants in VCF format were analyzed using Variant Effect Predictor (VEP) of the Ensemble database. The deleterious coding ns SNPs were detected by the web program SIFT, PolyPhen and Mutation Taster in addition to allele frequency and conservation score. The 3-D model of the human MLC1 protein was predicted using the CPH models 2.0 server. The resulting modeled structure with positions of mutations was viewed using Chimera 1.8 software. In MLC1 gene, 4 are nonsense, 18 are indels (frame shift mutations) and 10 potentially disrupt splicing. Six variants in MLC1 gene were predicted to be pathogenic using the same tools. The results of our study will facilitate future studies aimed to analyze the genetics of Leukodystrophy patients from different families from different populations.

Keywords: leukodystrophy, MLC1, SNPs, in silico

Introduction

Leukodystrophies are group of inherited disorders caused primarily by defective myelination of the central nervous system with or without peripheral nervous system involvement.1 There are over 30 of Leukodystrophy disorders have been described with various age of onset and clinical presentation but they all share white matter signals in brain MRI.2 Individual Leukodystrophy types are rare-although they vary depending on the population- but collectively they are not uncommon.3 Megalencephalic Leukodystrophy with sub cortical cysts is a type of Leukodystrophy caused by mutations in MLC1 gene and less commonly in HEPACAM Gene.4 The disease presents with early head enlargement, motor dysfunction and occasionally epilepsy. All kinds of mutations in MLC1 gene were described.4 However, high throughput technologies aimed to discover novel variants underlying these disorders are scarce, and there is a lot to be discovered. In silico analysis of SNPs in a gene known to cause a disease is a well effective and economic way of at least screen known variants deposited in public databases. And this approach has indeed proved valuable in many situations.5‒8 Since Leukodystrophy disorders are rarely studied especially in developing countries, approaches like in silico analysis, patients can be screened for known and predicted pathogenic variants first and if none found proceed to advanced technologies like whole genome or whole exome sequencing. This article aimed to analyze all SNPs in MLC1 gene in order to be used in screening programs for patients with Megalencephalic Leukodystrophy.

Materials and methods

The SNPs and their related protein sequences for MLC1 gene were retrieved from NCBI db SNP. Frame shift, nonsense and splicing variants were obtained from the NCBI database. The deleterious coding ns SNPs were detected by the web program SIFT and PolyPhen. Variants of both genes in VCF format were analyzed using Variant Effect Predictor (VEP) of the Ensemble database http://www.ensembl.org/Tools/VEP. Predicted pathogenic variants were filtered as follows: SIFT score <0.05, PolyPhen score >0.85 and Allele frequency <0.05. Pathogenicity of variants was verified using Mutation Taster and amino acid conservation from Alamut visual http://www.interactive-biosoftware.com/doc/alamut-visual/2.9/. Structural analysis was performed in order to evaluate and compare the stability of native and mutant structures. The 3-D model of the human MLC1 protein was predicted using the CPH models 2.0 server.9The resulting modeled structure with positions of mutations was viewed using Chimera 1.8 software.10

Results

The MLC1 gene contains 1471 SNPs, majority of which are intronic (44%) and upstream variants (22%). Majority of coding variants were missense (62%) and synonymous (30%), (Figure 1). In MLC1 gene, 4 are nonsense, 18 are indels (frame shift mutations) and 10 potentially disrupt splicing, (Table 1). In MLC1 gene, 6 missense variants were predicted to be pathogenic using in silico tools, (Table 2). The result of MLC1 protein modeling revealed globular proteins with multiple helices and beta sheets (Figure 2). The position of amino acid variants mentioned above is shown in (Figure 2).

Figure 1 Percentages of the consequences of variants in MLC1 gene (all) and (coding).
Figure 2 MLC1 protein modeled with CPH modeling server with number indicating position of missense amino acid variants (1=N218K, 2=A208V, 3=V260L, 4=V200F, 5=R193W) (Note that one variant R20G is not in the figure because the first 55 amino acids could not be modeled).

MLC1

Nonsense

Frame shift

Splicing

rs992764755

rs4513390

rs992020383

rs992830566

rs4569573

rs992021756

rs992920871

rs4569574

rs992057554

rs993014432

rs4569575

rs992070962

rs4600768

rs992340649

rs4838816

rs992349844

rs4838817

rs992369866

rs4838819

rs992430530

rs4838879

rs992566519

rs4838880

rs992712599

rs4838882

rs4838883

rs4990416

rs5771140

rs5771141

rs5771142

rs5771143

rs5771144

Table 1 SNPs causing nonsense, frame shift and splicing impairment mutations in MLC1 gene

SNP

AA*

SIFT (score)

Poly phen (score)

Mutation taster

AF**

CS

rs143061714

V260L

Deleterious (0)

Probably damaging (-0.987)

Disease causing

0.0006

High

rs568289086

A208V

Deleterious (0)

Probably damaging (-0.994)

Disease causing

0.0002

High

rs41302601

N218K

Deleterious (0)

Probably damaging (-0.997)

Disease causing

0.0022

High

rs78644350

V200F

Deleterious (0)

Probably damaging (-0.997)

Disease causing

0.0002

High

rs555304253

R193W

Deleterious (0)

Probably damaging (-0.997)

Disease causing

0.0002

High

rs533294413

R20G

Deleterious (0)

Probably damaging (-0.997)

Disease causing

0.0004

High

Table 2 Missense variants in MLC1 gene predicted to be pathogenic with SIFT (and its score) Poly Phen (and its score), Mutation Taster, allele frequency and conversation
*AA, Amino acid change; **AF, Allele frequency

Discussion

In silico analysis of SNPs in disease causing genes deposited in public databases and whose clinical significance is unknown is a valuable and economic method for preliminary screening studies especially for neglected diseases like Leukodystrophy. This study aimed to which variants in MLC1 gene are likely to be pathogenic using in silico prediction methods. The most common mutation we found were indel variants causing frame shift mutations. Frame shifting mutations are known to disrupt protein synthesis and very rarely don’t impair protein function.11 Frame shifting mutations were indeed found in many studies underlying these forms of Leukodystrophy.12‒15 Splicing impairing variants and non-sense variants were also found in our study and from pathogenesis point of view they are even stronger as culprits than either frame shift or missense damaging variants especially for disease which loss of function is their known mechanism16. Nonsense variants were found also in other studies17‒19 and so are splicing defects.15,20 Missense variants causing MLC1were previously reported in many studies.21 Judging from the in silico prediction methods which include conservation, allele frequency and tolerance of amino acid changes, our variants reported in our study are very likely to be pathogenic, but they are all novel and their association with these types of leukodystrophies await to be confirmed. These variants were deposited in NCBI public database with unknown clinical significance because all individuals sampled for genotyping were in heterozygous state and these diseases are recessive. The results of our study will facilitate future studies aimed to analyze the genetics of Leukodystrophy patients from different families from different populations. By implementing in silico predicted pathogenic variants in disease panels, this will perhaps lower the need to do exome sequencing and hence the cost of the study. The results of in silico predictive studies will also accelerate variants annotation keeping in pace with advancing international genome and exam studies.

Acknowledgements

None.

Conflicts of interest

The authors declare that they have no conflict of interest.

References

  1. Van Der Knaap MS, Scheper GC. Megalencephalic Leukoencephalopathy with Sub cortical Cysts. In: Adam MP, Ardinger HH, Pagon RA, editors. Gene Reviews(®). Seattle. 1993.
  2. Ashrafi MR, Tavasoli AR. Childhood leukodystrophies: A literature review of updates on new definitions, classification, diagnostic approach and management. Brain Dev. 2017;39(5):369–385.
  3. Bonkowsky JL, Nelson C, Kingston JL, et al. The burden of inherited leukodystrophies in children. Neurology. 2010;75(8):718–725.
  4. Van Der Knaap MS, Scheper GC. Megalencephalic Leukoencephalopathy with Sub cortical Cysts. In: Adam MP, Ardinger HH, Pagon RA, editors. Gene Reviews(®).Seattle. 1993.
  5. Amin M, Sanaa E, ME I. Computational Analysis of Single Nucleotide Polymorphisms associated with ENAM gene. J Biotechnol Sci Res. 2016;3(2):39–62.
  6. Hasan Y, Bakhit Y, Osama M, et al. In Silico Analysis of SNPs in PARK2 and PINK1 Genes That Potentially Cause Autosomal Recessive Parkinson Disease. Adv Bioinformatics. 2016;2016:e9313746.
  7. Kosaloglu Z, Bitzer J, Halama N, et al. In silico SNP analysis of the breast cancer antigen NY-BR-1. BMC Cancer. 2016;16(1):e901.
  8. Dabhi B, Mistry KN. In silico analysis of single nucleotide polymorphism (SNP) in human TNF-α gene. Meta Gene. 2014;24(2):586–595.
  9. Nielsen M, Lundegaard C, Lund O, et al. CPHmodels-3.0--remote homology modeling using structure-guided sequence profiles. Nucleic Acids Res. 2010;38:576–581.
  10. Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera--A visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605–1612.
  11. Drummond DA, Wilke CO. The evolutionary consequences of erroneous protein synthesis. Nat Rev Genet. 2009;10(10):715–724.
  12. Perkins KJ, Carey WF, Morris CP. An arylsulphatase A (ARSA) frame shift mutation (289insG) in metachromatic Leukodystrophy (MLD). J Mol Genet Med. 2005;1(1):3–4.
  13. Coulter Mackie MB, Gagnier L. Spectrum of mutations in the arylsulfatase A gene in a Canadian DNA collection including two novel frame shift mutations, a new missense mutation (C488R) and an MLD mutation (R84Q) in cis with a pseudo deficiency allele. Mol Genet Metab 2003;79(2):91–98.
  14. Shimada S, Shimojima K, Masuda T, et al. MLC1 mutations in Japanese patients with megalencephalic leukoencephalopathy with subcortical cysts. Hum Genome Var. 2014;1:e14019.
  15. Leegwater PA, Yuan BQ, Mulders J, et al. Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause Megalencephalic leukoencephalopathy with sub cortical cysts. Am J Hum Genet. 2001;68(4):831–838.
  16. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405‒24.
  17. Luzi P, Rafi MA, Rao HZ, et al. Sixteen novel mutations in the arylsulfatase A gene causing metachromatic leukodystrophy. Gene. 2013;530(2):323–328.
  18. Wang J, Shang J, Wu Y, et al. Identification of novel MLC1 mutations in Chinese patients with megalencephalic leukoencephalopathy with subcortical cysts (MLC). J Hum Genet. 2011;56(2):138–142.
  19. Harvey JS, Carey WF, Nelson PV, et al. Metachromatic Leukodystrophy: a nonsense mutation (Q486X) in the arylsulphatase A (ARSA) gene. Hum Mol Genet. 1994;3(1):e207.
  20. Kang DH, Lee DH, Hong YH, et al. Identification of a Novel Splicing Mutation in the ARSA Gene in a Patient with Late-infantile Form of Metachromatic Leukodystrophy. Korean J Lab Med. 2010;30(5):516‒520.
  21. López Hernández T, Sirisi S, Capdevila Nortes X, et al. Molecular mechanisms of MLC1 and GLIALCAM mutations in megalencephalic leukoencephalopathy with subcortical cysts. Hum Mol Genet. 2011;20(16):3266–3277.
Creative Commons Attribution License

©2018 Amin. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.